Back to search

France· FR:65669398

CEZIBOE 0,25 mg, solution injectable en seringue pré-remplie

A medicinal product containing cétrorélix (acétate de), registered in France by SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCEZIBOE 0,25 mg, solution injectable …ATC—REGISTER NO.FR:65669398PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CÉTRORÉLIX (ACÉTATE DE)
Manufacturer
SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930219508
    1 seringue(s) préremplie(s) en verre de 1 ml
    EUR 30.82

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cétrorélix (acétate de) in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cétrorélix (acétate de) products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Belgium · Ceziboe
  • Czechia · Cetrorelix Sun, Ceziboe
  • Germany · Ceziboe
  • Spain · Ceziboe Sun
  • United Kingdom (Northern Ireland) · Ceziboe
  • Greece · Ceziboe
  • Hungary · Ceziboe
  • Ireland · Ceziboe
  • Iceland · Cetrotide
  • Italy · Ceziboe
  • Liechtenstein · Cetrotide
  • Netherlands · Ceziboe
  • Norway · Cetrotide

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8a3201e2-c4a8-4c79-a992-2e7db9bc7d63
GET /v1/drugs/8a3201e2-c4a8-4c79-a992-2e7db9bc7d63?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65669398",
  "date_amm": "2020-12-15",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "CÉTRORÉLIX (ACÉTATE DE)",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about cétrorélix (acétate de).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.